<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36894607</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Motor unit number index (MUNIX) loss of 50% occurs in half the time of 50% functional loss according to the D50 disease progression model of ALS.</ArticleTitle><Pagination><StartPage>3981</StartPage><MedlinePgn>3981</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3981</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-30871-x</ELocationID><Abstract><AbstractText>Capturing disease progression in amyotrophic lateral sclerosis (ALS) is challenging and refinement of progression markers is urgently needed. This study introduces new motor unit number index (MUNIX), motor unit size index (MUSIX) and compound muscle action potential (CMAP) parameters called M50, MUSIX200 and CMAP50. M50 and CMAP50 indicate the time in months from symptom onset an ALS patient needs to lose 50% of MUNIX or CMAP in relation to the mean values of controls. MUSIX200 represents the time in months until doubling of the mean MUSIX of controls. We used MUNIX parameters of Musculi abductor pollicis brevis (APB), abductor digiti minimi (ADM) and tibialis anterior (TA) of 222 ALS patients. Embedded in the D50 disease progression model, disease aggressiveness and accumulation were analyzed separately. M50, CMAP50 and MUSIX200 significantly differed among disease aggressiveness subgroups (p&#x2009;&lt;&#x2009;0.001) regardless of disease accumulation. ALS patients with a low M50 had a significantly shorter survival compared to high M50 (median 32 versus 74&#xa0;months). M50 preceded the loss of global function (median of about 14&#xa0;months). M50, CMAP50 and MUSIX200 characterize the disease course in ALS in a new way and may be applied as early measures of disease progression.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ebersbach</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roediger</LastName><ForeName>Annekathrin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany. annekathrin.roediger@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbach</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appelfeller</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuemmler</LastName><ForeName>Anke</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stubendorff</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Axer</LastName><ForeName>Hubertus</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>Otto W</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Healthy Ageing, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence Precision Medicine in Inflammation, University of L&#xfc;beck, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004576" MajorTopicYN="N">Electromyography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36894607</ArticleId><ArticleId IdType="pmc">PMC9998642</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-30871-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-30871-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020 doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the Motor Unit Number Index (MUNIX): A 15-month longitudinal multicentre trial. J. Neurol. Neurosurg. Psychiatry. 2015;86:1172&#x2013;1179. doi: 10.1136/jnnp-2015-310509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310509</ArticleId><ArticleId IdType="pubmed">25935892</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Quality control of motor unit number index (MUNIX) measurements in 6 muscles in a single-subject "round-robin" setup. PLoS&#xa0;One. 2016;11:e0153948. doi: 10.1371/journal.pone.0153948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153948</ArticleId><ArticleId IdType="pmc">PMC4852906</ArticleId><ArticleId IdType="pubmed">27135747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashford J, Mills K, Shaw C. The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review. Clin. Neurophysiol. 2020;131:942&#x2013;950. doi: 10.1016/j.clinph.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.12.007</ArticleId><ArticleId IdType="pmc">PMC7083223</ArticleId><ArticleId IdType="pubmed">32044239</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatehi F, Grapperon AM, Fathi D, Delmont E, Attarian S. The utility of motor unit number index: A systematic review. Neurophysiol. Clin. 2018;48:251&#x2013;259. doi: 10.1016/j.neucli.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2018.09.001</ArticleId><ArticleId IdType="pubmed">30287192</ArticleId></ArticleIdList></Reference><Reference><Citation>Alix JJP, et al. Assessment of the reliability of the motor unit size index (MUSIX) in single subject "round-robin" and multi-centre settings. Clin. Neurophysiol. 2019;130:666&#x2013;674. doi: 10.1016/j.clinph.2019.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.01.020</ArticleId><ArticleId IdType="pubmed">30870802</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandedkar SD, Nandedkar DS, Barkhaus PE, Stalberg EV. Motor unit number index (MUNIX) IEEE Trans. Biomed. Eng. 2004;51:2209&#x2013;2211. doi: 10.1109/TBME.2004.834281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBME.2004.834281</ArticleId><ArticleId IdType="pubmed">15605872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandedkar SD, Barkhaus PE, Stalberg EV. Motor unit number index (MUNIX): Principle, method, and findings in healthy subjects and in patients with motor neuron disease. Muscle Nerve. 2010;42:798&#x2013;807. doi: 10.1002/mus.21824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21824</ArticleId><ArticleId IdType="pubmed">20976783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandedkar SD, Barkhaus PE, Stalberg EV, Neuwirth C, Weber M. Motor unit number index: Guidelines for recording signals and their analysis. Muscle Nerve. 2018;58:374&#x2013;380. doi: 10.1002/mus.26099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26099</ArticleId><ArticleId IdType="pubmed">29427557</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: Real world experience from 27 centres. Clin. Neurophysiol. 2018;129:1756&#x2013;1762. doi: 10.1016/j.clinph.2018.04.614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2018.04.614</ArticleId><ArticleId IdType="pubmed">29803404</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawel M, Kuzma-Kozakiewicz M. Does the MUNIX method reflect clinical dysfunction in amyotrophic lateral sclerosis: A practical experience. Medicine (Baltimore) 2016;95:e3647. doi: 10.1097/MD.0000000000003647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003647</ArticleId><ArticleId IdType="pmc">PMC4902529</ArticleId><ArticleId IdType="pubmed">27175687</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimaldi S, et al. Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis. Muscle Nerve. 2017;56:202&#x2013;206. doi: 10.1002/mus.25595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25595</ArticleId><ArticleId IdType="pubmed">28164325</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2017;128:495&#x2013;500. doi: 10.1016/j.clinph.2016.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.11.026</ArticleId><ArticleId IdType="pubmed">28043769</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K, et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88:2302&#x2013;2309. doi: 10.1212/WNL.0000000000004029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004029</ArticleId><ArticleId IdType="pubmed">28500227</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R, et al. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;25:102094. doi: 10.1016/j.nicl.2019.102094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102094</ArticleId><ArticleId IdType="pmc">PMC6940701</ArticleId><ArticleId IdType="pubmed">31896467</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R, et al. Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Hum. Brain Mapp. 2020 doi: 10.1002/hbm.25258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25258</ArticleId><ArticleId IdType="pmc">PMC7814763</ArticleId><ArticleId IdType="pubmed">33103324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreger M, et al. Cerebrospinal fluid neurofilament light chain (NfL) predicts disease aggressiveness in amyotrophic lateral sclerosis: An application of the D50 disease progression model. Front. Neurosci. 2021;15:651651. doi: 10.3389/fnins.2021.651651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.651651</ArticleId><ArticleId IdType="pmc">PMC8056017</ArticleId><ArticleId IdType="pubmed">33889072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebersbach T, et al. Motor unit number index (MUNIX) in the D50 disease progression model reflects disease accumulation independently of disease aggressiveness in ALS. Sci. Rep. 2022;12:15997. doi: 10.1038/s41598-022-19911-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-19911-0</ArticleId><ArticleId IdType="pmc">PMC9512899</ArticleId><ArticleId IdType="pubmed">36163485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 2020;131:1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J. Neurol. Sci. 1999;169:13&#x2013;21. doi: 10.1016/s0022-510x(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, et al. Reference values for the motor unit number index and the motor unit size index in five muscles. Muscle Nerve. 2020;61:657&#x2013;661. doi: 10.1002/mus.26837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26837</ArticleId><ArticleId IdType="pubmed">32068896</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmont E, et al. Motor unit number index as an individual biomarker: Reference limits of intra-individual variability over time in healthy subjects. Clin. Neurophysiol. 2020;131:2209&#x2013;2215. doi: 10.1016/j.clinph.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.06.019</ArticleId><ArticleId IdType="pubmed">32707479</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, et al. Motor Unit Number Index (MUNIX): Reference values of five different muscles in healthy subjects from a multi-centre study. Clin. Neurophysiol. 2011;122:1895&#x2013;1898. doi: 10.1016/j.clinph.2011.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2011.05.014</ArticleId><ArticleId IdType="pubmed">21689981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwirth C, Nandedkar S, Stalberg E, Weber M. Motor unit number index (MUNIX): A novel neurophysiological technique to follow disease progression in amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:379&#x2013;384. doi: 10.1002/mus.21707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21707</ArticleId><ArticleId IdType="pubmed">20589888</ArticleId></ArticleIdList></Reference><Reference><Citation>Escorcio-Bezerra ML, et al. Why averaging multiple MUNIX measures in the longitudinal assessment of patients with ALS? Clin. Neurophysiol. 2017;128:2392&#x2013;2396. doi: 10.1016/j.clinph.2017.09.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2017.09.104</ArticleId><ArticleId IdType="pubmed">29096211</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>